Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.
Bio-Rad Laboratories, Inc. (BIO) had Earnings per Share (EPS) (Diluted) of $26.65 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$693.20M |
|
$720.00M |
|
$348.00M |
|
$345.20M |
|
$812.10M |
|
$-118.90M |
|
$1.05B |
|
$929.20M |
|
$-100.30M |
|
$720.00M |
|
$720.00M |
|
$720.00M |
|
$-541.28M |
|
$-118.90M |
|
-- |
|
26.98M |
|
27.01M |
|
$26.69 |
|
|
Earnings per Share (EPS) (Diluted) |
$26.65 |
| Balance Sheet Financials | |
$2.91B |
|
$539.90M |
|
$7.67B |
|
$10.58B |
|
$517.00M |
|
$1.20B |
|
$2.61B |
|
$3.12B |
|
-- |
|
$6.70B |
|
$7.45B |
|
-- |
|
| Cash Flow Statement Financials | |
$532.20M |
|
$-189.70M |
|
$-283.20M |
|
$489.80M |
|
$532.20M |
|
$42.40M |
|
$58.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|